{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:32:53Z","timestamp":1787761973236,"version":"build-2784847793"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,10,17]],"date-time":"2014-10-17T00:00:00Z","timestamp":1413504000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosurg Rev"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1007\/s10143-014-0579-x","type":"journal-article","created":{"date-parts":[[2014,10,16]],"date-time":"2014-10-16T02:42:55Z","timestamp":1413427375000},"page":"89-99","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Immunohistochemical expression of receptor tyrosine kinase PDGFR-\u03b1, c-Met, and EGFR in skull base chordoma"],"prefix":"10.1007","volume":"38","author":[{"given":"R.","family":"Akhavan-Sigari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Abili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. R.","family":"Gaab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Rohde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Zafar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Emami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Ostertag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,10,17]]},"reference":[{"issue":"3","key":"579_CR1","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1046\/j.1365-2559.2002.00353.x","volume":"40","author":"S-I Aishima","year":"2002","unstructured":"Aishima S-I, Taguchi K-I, Sugimachi K, Shimada M, Sugimachi K, Tsuneyoshi M (2002) c-erbB-2 and c-Met expression relates to cholangiocarcinogenesis and progression of intrahepatic cholangiocarcinoma. Histopathology 40(3):269\u2013278","journal-title":"Histopathology"},{"issue":"1","key":"579_CR2","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10143-013-0495-5","volume":"37","author":"R Akhavan-Sigari","year":"2014","unstructured":"Akhavan-Sigari R, Gaab MR, Rohde V, Brandis A, Tezval H, Abili M et al (2014) Expression of vascular endothelial growth factor receptor 2 (VEGFR-2), inducible nitric oxide synthase (iNOS), and Ki-M1P in skull base chordoma: a series of 145 tumors. Neurosurg Rev 37(1):79\u201388","journal-title":"Neurosurg Rev"},{"issue":"12","key":"579_CR3","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1200\/JCO.2009.21.9170","volume":"27","author":"CJ Allegra","year":"2009","unstructured":"Allegra CJ, Jessup JM, Somerfield MR, Hamilton SR, Hammond EH, Hayes DF et al (2009) American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy. J Clin Oncol 27(12):2091\u20132096","journal-title":"J Clin Oncol"},{"issue":"3","key":"579_CR4","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1245\/ASO.2003.06.002","volume":"10","author":"D Baratti","year":"2003","unstructured":"Baratti D, Gronchi A, Pennacchioli E, Lozza L, Colecchia M, Fiore M et al (2003) Chordoma: natural history and results in 28 patients treated at a single institution. Ann Surg Oncol 10(3):291\u2013296","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"579_CR5","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.surneu.2006.11.046","volume":"68","author":"F Bayrakli","year":"2007","unstructured":"Bayrakli F, Guney I, Kilic T, Ozek M, Pamir MN (2007) New candidate chromosomal regions for chordoma development. Surg Neurol 68(4):425\u2013430, discussion 430","journal-title":"Surg Neurol"},{"issue":"7","key":"579_CR6","first-page":"2322","volume":"82","author":"A Belfiore","year":"1997","unstructured":"Belfiore A, Gangemi P, Costantino A, Russo G, Santonocito GM, Ippolito O et al (1997) Negative\/low expression of the Met\/hepatocyte growth factor receptor identifies papillary thyroid carcinomas with high risk of distant metastases. J Clin Endocrinol Metab 82(7):2322\u20132328","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"579_CR7","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.critrevonc.2003.08.004","volume":"50","author":"A Bennasroune","year":"2004","unstructured":"Bennasroune A, Gardin A, Aunis D, Cr\u00e9mel G, Hubert P (2004) Tyrosine kinase receptors as attractive targets of cancer therapy. Crit Rev Oncol Hematol 50(1):23\u201338","journal-title":"Crit Rev Oncol Hematol"},{"issue":"9","key":"579_CR8","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1002\/(SICI)1097-0142(20000501)88:9<2122::AID-CNCR19>3.0.CO;2-1","volume":"88","author":"P Bergh","year":"2000","unstructured":"Bergh P, Kindblom LG, Gunterberg B, Remotti F, Ryd W, Meis-Kindblom JM (2000) Prognostic factors in chordoma of the sacrum and mobile spine: a study of 39 patients. Cancer 88(9):2122\u20132134","journal-title":"Cancer"},{"key":"579_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0070-2153(08)60753-X","volume":"48","author":"B Brand-Saberi","year":"2000","unstructured":"Brand-Saberi B, Christ B (2000) Evolution and development of distinct cell lineages derived from somites. Curr Top Dev Biol 48:1\u201342","journal-title":"Curr Top Dev Biol"},{"issue":"9","key":"579_CR10","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1002\/cncr.20618","volume":"101","author":"PG Casali","year":"2004","unstructured":"Casali PG, Messina A, Stacchiotti S, Tamborini E, Crippa F, Gronchi A et al (2004) Imatinib mesylate in chordoma. Cancer 101(9):2086\u20132097","journal-title":"Cancer"},{"issue":"15","key":"579_CR11","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1200\/JCO.2005.02.170","volume":"23","author":"R Chugh","year":"2005","unstructured":"Chugh R, Dunn R, Zalupski MM, Biermann JS, Sondak VK, Mace JR et al (2005) Phase II study of 9-nitro-camptothecin in patients with advanced chordoma or soft tissue sarcoma. J Clin Oncol 23(15):3597\u20133604","journal-title":"J Clin Oncol"},{"issue":"11","key":"579_CR12","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1056\/NEJMra0707704","volume":"358","author":"F Ciardiello","year":"2008","unstructured":"Ciardiello F, Tortora G (2008) EGFR antagonists in cancer treatment. N Engl J Med 358(11):1160\u20131174","journal-title":"N Engl J Med"},{"key":"579_CR13","first-page":"131","volume":"65","author":"PM Comoglio","year":"1993","unstructured":"Comoglio PM (1993) Structure, biosynthesis and biochemical properties of the HGF receptor in normal and malignant cells. EXS 65:131\u2013165","journal-title":"EXS"},{"issue":"3","key":"579_CR14","first-page":"753","volume":"51","author":"ML Deniz","year":"2002","unstructured":"Deniz ML, Kili\u00e7 T, Almaata I, Kurtkaya O, Sav A, Pamir MN (2002) Expression of growth factors and structural proteins in chordomas: basic fibroblast growth factor, transforming growth factor alpha, and fibronectin are correlated with recurrence. Neurosurgery 51(3):753\u2013760, discussion 760","journal-title":"Neurosurgery"},{"issue":"1","key":"579_CR15","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1365-2990.2007.00873.x","volume":"34","author":"JH Fasig","year":"2008","unstructured":"Fasig JH, Dupont WD, LaFleur BJ, Olson SJ, Cates JMM (2008) Immunohistochemical analysis of receptor tyrosine kinase signal transduction activity in chordoma. Neuropathol Appl Neurobiol 34(1):95\u2013104","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"15","key":"579_CR16","doi-asserted-by":"crossref","first-page":"5844","DOI":"10.1073\/pnas.86.15.5844","volume":"86","author":"E Gherardi","year":"1989","unstructured":"Gherardi E, Gray J, Stoker M, Perryman M, Furlong R (1989) Purification of scatter factor, a fibroblast-derived basic protein that modulates epithelial interactions and movement. Proc Natl Acad Sci U S A 86(15):5844\u20135848","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"579_CR17","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1159\/000096283","volume":"29","author":"H Hof","year":"2006","unstructured":"Hof H, Welzel T, Debus J (2006) Effectiveness of cetuximab\/gefitinib in the therapy of a sacral chordoma. Onkologie 29(12):572\u2013574","journal-title":"Onkologie"},{"issue":"4","key":"579_CR18","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1177\/29.4.6166661","volume":"29","author":"SM Hsu","year":"1981","unstructured":"Hsu SM, Raine L, Fanger H (1981) Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29(4):577\u2013580","journal-title":"J Histochem Cytochem"},{"issue":"5","key":"579_CR19","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/path.1945","volume":"208","author":"MS Lagonigro","year":"2006","unstructured":"Lagonigro MS, Tamborini E, Negri T, Staurengo S, Dagrada GP, Miselli F et al (2006) PDGFRalpha, PDGFRbeta and KIT expression\/activation in conventional chondrosarcoma. J Pathol 208(5):615\u2013623","journal-title":"J Pathol"},{"key":"579_CR20","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1186\/1471-2407-11-423","volume":"11","author":"SG Launay","year":"2011","unstructured":"Launay SG, Chetaille B, Medina F, Perrot D, Nazarian S, Guiramand J et al (2011) Efficacy of epidermal growth factor receptor targeting in advanced chordoma: case report and literature review. BMC Cancer 11:423","journal-title":"BMC Cancer"},{"issue":"1","key":"579_CR21","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1080\/02841860802266672","volume":"48","author":"O Lind\u00e9n","year":"2009","unstructured":"Lind\u00e9n O, Stenberg L, Kjell\u00e9n E (2009) Regression of cervical spinal cord compression in a patient with chordoma following treatment with cetuximab and gefitinib. Acta Oncol 48(1):158\u2013159","journal-title":"Acta Oncol"},{"issue":"1","key":"579_CR22","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0006-291X(91)90887-D","volume":"176","author":"K Matsumoto","year":"1991","unstructured":"Matsumoto K, Tajima H, Nakamura T (1991) Hepatocyte growth factor is a potent stimulator of human melanocyte DNA synthesis and growth. Biochem Biophys Res Commun 176(1):45\u201351","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"579_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1008947301735","volume":"12","author":"ML McMaster","year":"2001","unstructured":"McMaster ML, Goldstein AM, Bromley CM, Ishibe N, Parry DM (2001) Chordoma: incidence and survival patterns in the United States, 1973\u20131995. Cancer Causes Control 12(1):1\u201311","journal-title":"Cancer Causes Control"},{"issue":"5","key":"579_CR24","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/0092-8674(91)90363-4","volume":"67","author":"R Montesano","year":"1991","unstructured":"Montesano R, Matsumoto K, Nakamura T, Orci L (1991) Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell 67(5):901\u2013908","journal-title":"Cell"},{"issue":"2","key":"579_CR25","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1309\/5DLWL8EA7JUDWNVL","volume":"124","author":"T Naka","year":"2005","unstructured":"Naka T, Boltze C, Kuester D, Samii A, Herold C, Ostertag H et al (2005) Intralesional fibrous septum in chordoma: a clinicopathologic and immunohistochemical study of 122 lesions. Am J Clin Pathol 124(2):288\u2013294","journal-title":"Am J Clin Pathol"},{"issue":"6","key":"579_CR26","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1309\/C8T7APJDAUPR8TLL","volume":"122","author":"T Naka","year":"2004","unstructured":"Naka T, Boltze C, Kuester D, Schulz T-O, Samii A, Herold C et al (2004) Expression of matrix metalloproteinase (MMP)-1, MMP-2, MMP-9, cathepsin B, and urokinase plasminogen activator in non-skull base chordoma. Am J Clin Pathol 122(6):926\u2013930","journal-title":"Am J Clin Pathol"},{"issue":"9","key":"579_CR27","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1002\/cncr.11756","volume":"98","author":"T Naka","year":"2003","unstructured":"Naka T, Boltze C, Samii A, Herold C, Ostertag H, Iwamoto Y et al (2003) Skull base and nonskull base chordomas: clinicopathologic and immunohistochemical study with special reference to nuclear pleomorphism and proliferative ability. Cancer 98(9):1934\u20131941","journal-title":"Cancer"},{"issue":"8","key":"579_CR28","first-page":"832","volume":"10","author":"T Naka","year":"1997","unstructured":"Naka T, Iwamoto Y, Shinohara N, Ushijima M, Chuman H, Tsuneyoshi M (1997) Expression of c-met proto-oncogene product (c-MET) in benign and malignant bone tumors. Mod Pathol 10(8):832\u2013838","journal-title":"Mod Pathol"},{"issue":"1","key":"579_CR29","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/cncr.23141","volume":"112","author":"T Naka","year":"2008","unstructured":"Naka T, Kuester D, Boltze C, Scheil-Bertram S, Samii A, Herold C et al (2008) Expression of hepatocyte growth factor and c-MET in skull base chordoma. Cancer 112(1):104\u2013110","journal-title":"Cancer"},{"issue":"6248","key":"579_CR30","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/342440a0","volume":"342","author":"T Nakamura","year":"1989","unstructured":"Nakamura T, Nishizawa T, Hagiya M, Seki T, Shimonishi M, Sugimura A et al (1989) Molecular cloning and expression of human hepatocyte growth factor. Nature 342(6248):440\u2013443","journal-title":"Nature"},{"issue":"4","key":"579_CR31","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1046\/j.1365-2559.2000.00847.x","volume":"36","author":"L Nakopoulou","year":"2000","unstructured":"Nakopoulou L, Gakiopoulou H, Keramopoulos A, Giannopoulou I, Athanassiadou P, Mavrommatis J et al (2000) c-met tyrosine kinase receptor expression is associated with abnormal beta-catenin expression and favourable prognostic factors in invasive breast carcinoma. Histopathology 36(4):313\u2013325","journal-title":"Histopathology"},{"issue":"1","key":"579_CR32","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/sj.bjc.6603542","volume":"96","author":"T Negri","year":"2007","unstructured":"Negri T, Casieri P, Miselli F, Orsenigo M, Piacenza C, Stacchiotti S et al (2007) Evidence for PDGFRA, PDGFRB and KIT deregulation in an NSCLC patient. Br J Cancer 96(1):180\u2013181","journal-title":"Br J Cancer"},{"issue":"8","key":"579_CR33","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1002\/1097-0142(19941015)74:8<2261::AID-CNCR2820740809>3.0.CO;2-0","volume":"74","author":"JX O\u2019Connell","year":"1994","unstructured":"O\u2019Connell JX, Renard LG, Liebsch NJ, Efird JT, Munzenrider JE, Rosenberg AE (1994) Base of skull chordoma. A correlative study of histologic and clinical features of 62 cases. Cancer 74(8):2261\u20132267","journal-title":"Cancer"},{"issue":"25","key":"579_CR34","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1097\/BRS.0b013e31817e2d1e","volume":"33","author":"E Ostroumov","year":"2008","unstructured":"Ostroumov E, Hunter CJ (2008) Identifying mechanisms for therapeutic intervention in chordoma: c-Met oncoprotein. Spine 33(25):2774\u20132780","journal-title":"Spine"},{"issue":"3","key":"579_CR35","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/ijc.2910490302","volume":"49","author":"M Prat","year":"1991","unstructured":"Prat M, Narsimhan RP, Crepaldi T, Nicotra MR, Natali PG, Comoglio PM (1991) The receptor encoded by the human c-MET oncogene is expressed in hepatocytes, epithelial cells and solid tumors. Int J Cancer 49(3):323\u2013328","journal-title":"Int J Cancer"},{"issue":"2","key":"579_CR36","first-page":"81","volume":"60","author":"K Ptaszy\u0144ski","year":"2009","unstructured":"Ptaszy\u0144ski K, Szumera-Cie\u0107kiewicz A, Owczarek J, Mrozkowiak A, Pekul M, Bara\u0144ska J et al (2009) Epidermal growth factor receptor (EGFR) status in chordoma. Pol J Pathol 60(2):81\u201387","journal-title":"Pol J Pathol"},{"issue":"1","key":"579_CR37","first-page":"24","volume":"7","author":"DL Rimm","year":"2001","unstructured":"Rimm DL, Camp RL, Charette LA, Costa J, Olsen DA, Reiss M (2001) Tissue microarray: a new technology for amplification of tissue resources. Cancer J 7(1):24\u201331","journal-title":"Cancer J"},{"issue":"3","key":"579_CR38","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/(SICI)1096-9896(199611)180:3<266::AID-PATH658>3.0.CO;2-Q","volume":"180","author":"LP Ruco","year":"1996","unstructured":"Ruco LP, Ranalli T, Marzullo A, Bianco P, Prat M, Comoglio PM et al (1996) Expression of Met protein in thyroid tumours. J Pathol 180(3):266\u2013270","journal-title":"J Pathol"},{"issue":"3","key":"579_CR39","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/path.2818","volume":"223","author":"A Shalaby","year":"2011","unstructured":"Shalaby A, Presneau N, Ye H, Halai D, Berisha F, Idowu B et al (2011) The role of epidermal growth factor receptor in chordoma pathogenesis: a potential therapeutic target. J Pathol 223(3):336\u2013346","journal-title":"J Pathol"},{"issue":"11","key":"579_CR40","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/j.clinthera.2006.11.015","volume":"28","author":"T Shih","year":"2006","unstructured":"Shih T, Lindley C (2006) Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignancies. Clin Ther 28(11):1779\u20131802","journal-title":"Clin Ther"},{"issue":"11","key":"579_CR41","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1093\/annonc\/mdp210","volume":"20","author":"S Stacchiotti","year":"2009","unstructured":"Stacchiotti S, Marrari A, Tamborini E, Palassini E, Virdis E, Messina A et al (2009) Response to imatinib plus sirolimus in advanced chordoma. Ann Oncol 20(11):1886\u20131894","journal-title":"Ann Oncol"},{"issue":"6119","key":"579_CR42","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/327239a0","volume":"327","author":"M Stoker","year":"1987","unstructured":"Stoker M, Gherardi E, Perryman M, Gray J (1987) Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature 327(6119):239\u2013242","journal-title":"Nature"},{"issue":"3","key":"579_CR43","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1158\/1078-0432.CCR-03-0059","volume":"10","author":"E Tamborini","year":"2004","unstructured":"Tamborini E, Bonadiman L, Greco A, Gronchi A, Riva C, Bertulli R et al (2004) Expression of ligand-activated KIT and platelet-derived growth factor receptor beta tyrosine kinase receptors in synovial sarcoma. Clin Cancer Res 10(3):938\u2013943","journal-title":"Clin Cancer Res"},{"issue":"23","key":"579_CR44","doi-asserted-by":"crossref","first-page":"6920","DOI":"10.1158\/1078-0432.CCR-06-1584","volume":"12","author":"E Tamborini","year":"2006","unstructured":"Tamborini E, Miselli F, Negri T, Lagonigro MS, Staurengo S, Dagrada GP et al (2006) Molecular and biochemical analyses of platelet-derived growth factor receptor (PDGFR) B, PDGFRA, and KIT receptors in chordomas. Clin Cancer Res 12(23):6920\u20136928","journal-title":"Clin Cancer Res"},{"issue":"2","key":"579_CR45","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0046-8177(98)90229-5","volume":"29","author":"T Terada","year":"1998","unstructured":"Terada T, Nakanuma Y, Sirica AE (1998) Immunohistochemical demonstration of MET overexpression in human intrahepatic cholangiocarcinoma and in hepatolithiasis. Hum Pathol 29(2):175\u2013180","journal-title":"Hum Pathol"},{"issue":"5074","key":"579_CR46","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1126\/science.1387731","volume":"257","author":"I Tsarfaty","year":"1992","unstructured":"Tsarfaty I, Resau JH, Rulong S, Keydar I, Faletto DL, Vande Woude GF (1992) The met proto-oncogene receptor and lumen formation. Science 257(5074):1258\u20131261","journal-title":"Science"},{"issue":"1","key":"579_CR47","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1200\/JCO.2004.05.114","volume":"22","author":"U Vanhoefer","year":"2004","unstructured":"Vanhoefer U, Tewes M, Rojo F, Dirsch O, Schleucher N, Rosen O et al (2004) Phase I study of the humanized antiepidermal growth factor receptor monoclonal antibody EMD72000 in patients with advanced solid tumors that express the epidermal growth factor receptor. J Clin Oncol 22(1):175\u2013184","journal-title":"J Clin Oncol"},{"issue":"2","key":"579_CR48","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/00000478-198303000-00006","volume":"7","author":"R Volpe","year":"1983","unstructured":"Volpe R, Mazabraud A (1983) A clinicopathologic review of 25 cases of chordoma (a pleomorphic and metastasizing neoplasm). Am J Surg Pathol 7(2):161\u2013170","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"579_CR49","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/path.1969","volume":"209","author":"S Vujovic","year":"2006","unstructured":"Vujovic S, Henderson S, Presneau N, Odell E, Jacques T, Tirabosco R et al (2006) Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas. J Pathol 209(2):157\u2013165","journal-title":"J Pathol"},{"issue":"8","key":"579_CR50","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1001\/archotol.131.8.707","volume":"131","author":"PM Weinberger","year":"2005","unstructured":"Weinberger PM, Yu Z, Kowalski D, Joe J, Manger P, Psyrri A et al (2005) Differential expression of epidermal growth factor receptor, c-Met, and HER2\/neu in chordoma compared with 17 other malignancies. Arch Otolaryngol Head Neck Surg 131(8):707\u2013711","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"1","key":"579_CR51","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1200\/JCO.2006.09.2775","volume":"25","author":"AC Wolff","year":"2007","unstructured":"Wolff AC, Hammond MEH, Schwartz JN, Hagerty KL, Allred DC, Cote RJ et al (2007) American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 25(1):118\u2013145","journal-title":"J Clin Oncol"},{"issue":"8","key":"579_CR52","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1172\/JCI32278","volume":"117","author":"H Zhang","year":"2007","unstructured":"Zhang H, Berezov A, Wang Q, Zhang G, Drebin J, Murali R et al (2007) ErbB receptors: from oncogenes to targeted cancer therapies. J Clin Invest 117(8):2051\u20132058","journal-title":"J Clin Invest"}],"container-title":["Neurosurgical Review"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-014-0579-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10143-014-0579-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-014-0579-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T23:29:39Z","timestamp":1717457379000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10143-014-0579-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,17]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["579"],"URL":"https:\/\/doi.org\/10.1007\/s10143-014-0579-x","relation":{},"ISSN":["0344-5607","1437-2320"],"issn-type":[{"value":"0344-5607","type":"print"},{"value":"1437-2320","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,17]]}}}